Literature DB >> 30715469

Influenza Vaccines: Good, but We Can Do Better.

Catharine I Paules1, Anthony S Fauci2.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 30715469      PMCID： PMC6787547          DOI： 10.1093/infdis/jiy633

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  9 in total

Review 1.  Influenza.

Authors:  Catharine Paules; Kanta Subbarao
Journal:  Lancet       Date:  2017-03-13       Impact factor: 79.321

2.  A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases.

Authors:  Emily J Erbelding; Diane J Post; Erik J Stemmy; Paul C Roberts; Alison Deckhut Augustine; Stacy Ferguson; Catharine I Paules; Barney S Graham; Anthony S Fauci
Journal:  J Infect Dis       Date:  2018-07-02       Impact factor: 5.226

Review 3.  The road to a more effective influenza vaccine: Up to date studies and future prospects.

Authors:  Kaori Sano; Akira Ainai; Tadaki Suzuki; Hideki Hasegawa
Journal:  Vaccine       Date:  2017-08-31       Impact factor: 3.641

4.  Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies.

Authors:  Masaru Kanekiyo; Chih-Jen Wei; Hadi M Yassine; Patrick M McTamney; Jeffrey C Boyington; James R R Whittle; Srinivas S Rao; Wing-Pui Kong; Lingshu Wang; Gary J Nabel
Journal:  Nature       Date:  2013-05-22       Impact factor: 49.962

5.  Estimates of global seasonal influenza-associated respiratory mortality: a modelling study.

Authors:  A Danielle Iuliano; Katherine M Roguski; Howard H Chang; David J Muscatello; Rakhee Palekar; Stefano Tempia; Cheryl Cohen; Jon Michael Gran; Dena Schanzer; Benjamin J Cowling; Peng Wu; Jan Kyncl; Li Wei Ang; Minah Park; Monika Redlberger-Fritz; Hongjie Yu; Laura Espenhain; Anand Krishnan; Gideon Emukule; Liselotte van Asten; Susana Pereira da Silva; Suchunya Aungkulanon; Udo Buchholz; Marc-Alain Widdowson; Joseph S Bresee
Journal:  Lancet       Date:  2017-12-14       Impact factor: 79.321

6.  Increase in Human Infections with Avian Influenza A(H7N9) Virus During the Fifth Epidemic - China, October 2016-February 2017.

Authors:  A Danielle Iuliano; Yunho Jang; Joyce Jones; C Todd Davis; David E Wentworth; Timothy M Uyeki; Katherine Roguski; Mark G Thompson; Larisa Gubareva; Alicia M Fry; Erin Burns; Susan Trock; Suizan Zhou; Jacqueline M Katz; Daniel B Jernigan
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-03-10       Impact factor: 17.586

7.  Universal influenza vaccines: Shifting to better vaccines.

Authors:  Francesco Berlanda Scorza; Vadim Tsvetnitsky; John J Donnelly
Journal:  Vaccine       Date:  2016-03-31       Impact factor: 3.641

8.  Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.

Authors:  Seth J Zost; Kaela Parkhouse; Megan E Gumina; Kangchon Kim; Sebastian Diaz Perez; Patrick C Wilson; John J Treanor; Andrea J Sant; Sarah Cobey; Scott E Hensley
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-06       Impact factor: 11.205

9.  Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses.

Authors:  Kapil Bahl; Joe J Senn; Olga Yuzhakov; Alex Bulychev; Luis A Brito; Kimberly J Hassett; Michael E Laska; Mike Smith; Örn Almarsson; James Thompson; Amilcar Mick Ribeiro; Mike Watson; Tal Zaks; Giuseppe Ciaramella
Journal:  Mol Ther       Date:  2017-04-27       Impact factor: 12.910
  9 in total
  15 in total

1.  The effect of sex on responses to influenza vaccines.

Authors:  Lucy Denly
Journal:  Hum Vaccin Immunother       Date:  2020-11-12       Impact factor: 3.452

2.  Pre-existing immunity to influenza virus hemagglutinin stalk might drive selection for antibody-escape mutant viruses in a human challenge model.

Authors:  Jae-Keun Park; Yongli Xiao; Mitchell D Ramuta; Luz Angela Rosas; Sharon Fong; Alexis M Matthews; Ashley D Freeman; Monica A Gouzoulis; Natalia A Batchenkova; Xingdong Yang; Kelsey Scherler; Li Qi; Susan Reed; Rani Athota; Lindsay Czajkowski; Alison Han; David M Morens; Kathie-Anne Walters; Matthew J Memoli; John C Kash; Jeffery K Taubenberger
Journal:  Nat Med       Date:  2020-06-29       Impact factor: 53.440

3.  Seasonal influenza vaccination expands hemagglutinin-specific antibody breadth to older and future A/H3N2 viruses.

Authors:  Nina Urke Ertesvåg; Rebecca Jane Cox; Sarah Larteley Lartey; Kristin G-I Mohn; Karl Albert Brokstad; Mai-Chi Trieu
Journal:  NPJ Vaccines       Date:  2022-06-24       Impact factor: 9.399

4.  Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.

Authors:  Michelle C Crank; John R Mascola; Barney S Graham
Journal:  J Infect Dis       Date:  2019-04-08       Impact factor: 5.226

5.  Selective Engagement of FcγRIV by a M2e-Specific Single Domain Antibody Construct Protects Against Influenza A Virus Infection.

Authors:  Dorien De Vlieger; Katja Hoffmann; Inge Van Molle; Wim Nerinckx; Lien Van Hoecke; Marlies Ballegeer; Sarah Creytens; Han Remaut; Hartmut Hengel; Bert Schepens; Xavier Saelens
Journal:  Front Immunol       Date:  2019-12-12       Impact factor: 7.561

6.  Identification and Structural Aspects of G-Quadruplex-Forming Sequences from the Influenza A Virus Genome.

Authors:  Maria Tomaszewska; Marta Szabat; Karolina Zielińska; Ryszard Kierzek
Journal:  Int J Mol Sci       Date:  2021-06-02       Impact factor: 5.923

7.  Facial Paralysis Following Influenza Vaccination: A Disproportionality Analysis Using the Vaccine Adverse Event Reporting System Database.

Authors:  Ashwin Kamath; Nivedita Maity; Manel Arjun Nayak
Journal:  Clin Drug Investig       Date:  2020-09       Impact factor: 2.859

Review 8.  Next-generation influenza vaccines: opportunities and challenges.

Authors:  Chih-Jen Wei; Michelle C Crank; John Shiver; Barney S Graham; John R Mascola; Gary J Nabel
Journal:  Nat Rev Drug Discov       Date:  2020-02-14       Impact factor: 84.694

Review 9.  Self-amplifying RNA vaccines for infectious diseases.

Authors:  Kristie Bloom; Fiona van den Berg; Patrick Arbuthnot
Journal:  Gene Ther       Date:  2020-10-22       Impact factor: 5.250

10.  A Vaccine Displaying a Trimeric Influenza-A HA Stem Protein on Capsid-Like Particles Elicits Potent and Long-Lasting Protection in Mice.

Authors:  Susan Thrane; Kara-Lee Aves; Ida E M Uddbäck; Christoph M Janitzek; Julianna Han; Yuhe R Yang; Andrew B Ward; Thor G Theander; Morten A Nielsen; Ali Salanti; Allan R Thomsen; Jan P Christensen; Adam F Sander
Journal:  Vaccines (Basel)       Date:  2020-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.